Stephanie Combs PhD

Stephanie E. Combs is a leading expert in the field of radiation oncology. Her core expertise lies in high-precision radiation therapy (stereotaxy, IMRT/IGRT/ART, protons/heavy ions), radiation biology, and combination therapies with radiation. Her scientific work includes therapy optimization of brain and skull base tumors, biomarkers in radiation oncology, pediatric oncology, gastrointestinal oncology, uro-oncology, gynecological oncology, radiochemotherapy, and radioimmunotherapy. Stephanie E. Combs works with her interdisciplinary team on various platforms. She implements this networking out of conviction: She is the Director of the Institute of Radiation Medicine at Helmholtz Munich and Director of the Department of Radiation Oncology at the Technical University of Munich (TUM), Senate Chair of the TUM and several national and EU-wide research networks. The Institute of Radiation Medicine works closely with the Department of Radiooncology at the University Hospital Rechts der Isar and physicians throughout Germany and Europe and is thus able to research findings gained in the laboratory on patients and bring new therapeutic approaches into the clinic.

Prof. Dr. Combs studied medicine at the University of Heidelberg, Germany, with temporary stays abroad at the Eastern Virginia Medical School, Norfolk, VA, USA, and the University of Texas (UTHSCSA), San Antonio, TX, USA. After receiving her doctorate in 2003, she worked as a research assistant in Heidelberg. In 2009, she completed her habilitation. In 2011, she worked as a senior physician at the Department of Radiation Oncology at Heidelberg University Hospital, Germany. Since 2014, Prof. Combs has been Director of the Department of Radiation Oncology at TUM, Munich, Germany, and since 2015 she has been Director of the Institute of Radiation Medicine at Helmholtz Munich. In 2015, she initiated a master's program, Master of Radiobiology. In 2019, Prof. Combs became Chairman of the Senate of TUM.